News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Cybin Goes Public on the NEO Exchange
Cybin Inc.
MagicMed Industries Announces $2.5 Million Unit Offering Led by Gravitas Securities
Enveric Biosciences
Canadian Rapid Treatment Center of Excellence Opens Second Location Providing Ketamine Treatment for Adults with Depression
Braxia Scientific Corp.
COMPASS Pathways Joins The Psychiatry Consortium In A Collaboration To Accelerate Drug Discovery in Mental Health Care
Compass Pathways
Joseph del Moral | Founder & CEO, Field Trip Health
Field Trip Health
COMPASS Pathways PLC To Announce Third Quarter 2020 Financial Results On November 12, 2020
Compass Pathways
Novamind to Discuss the Role of Ketamine in Eating Disorder Treatment at Leading Psychiatry Conference
Novamind Inc.
Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Signs Psilocybin Manufacturing Agreement
Nova Mentis Life Science
Field Trip Health Releases Renderings of Jamaica Facility
Field Trip Health
Pure Extracts Technology Corp. To Commence Trading On The Canadian Securities Exchange
Pure Extracts Corp
Robert Roscow | CSO, Mydecine Innovations Group
Mydecine Innovations Group
Nova Mentis Life Science Signs Amalgamation Agreement to Acquire 100% of Pilz BioScience Corp.
Nova Mentis Life Science
MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD
Mind Medicine (MindMed)
Core One Labs Signs Letter of Intent to Sell Certain Assets
Core One Labs Inc.
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.